CNSY Cerenome, Inc.
$1.57▼ -4.27%
Healthcare
Other
Volume 74.0K
Avg Volume (10D) 72.8K
Key Metrics & Fundamentals
Market Cap
$11.92M
P/E Ratio
0.5
Div Yield
0.00%
52W Range
1.49 - 19.00
% vs 50 MA
-29.59%
% vs 200 MA
-67.43%
RSI-14
36.4
MACD Histogram
+0.0300
Beta (1Y vs SPY)
1.92
Free Cash Flow
-$7.63M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$8.86M
COGS
–
Operating Exp
$9.06M
Operating Income
-$9.06M
EBIT
-$9.06M
Pretax Income
-$9.01M
Net Income
-$9.01M
EPS (Diluted)
-1.31
Price & Volume History
Loading chart…
Recent News
How Much Downside Is Left In Moderna Stock?
Trefis · Oct 23, 2026 4:00 AM ET
New Strong Sell Stocks for October 22nd
Zacks · Oct 22, 2026 6:53 AM ET
Cerenome Announces New Dual Mechanism of Action Featuring Lethal DNA Damage and Beneficial Immunomodulation Supporting Lead Investigational Drug REYOBIQ™
GlobeNewswire · Oct 21, 2026 7:30 AM ET
What Is The Case For Waiting On Moderna Stock?
Trefis · Oct 16, 2026 10:44 AM ET
New Strong Sell Stocks for October 15th
Zacks · Oct 15, 2026 3:47 AM ET
Where Could Moderna's Next Growth Come From?
Trefis · Oct 12, 2026 5:01 PM ET
Cerenome Secures In-Network Agreement with Florida Blue for CNSide® CSF Tumor Cell Enumeration and Molecular Profile Tests
GlobeNewswire · Oct 8, 2026 7:30 AM ET
Cerenome Launches CNSide® CSF Molecular Profile Tests
GlobeNewswire · Oct 6, 2026 7:30 AM ET
Cerenome Expects $1.55 Million in CNSide® Third Quarter Gross Billings
GlobeNewswire · Sep 30, 2026 7:30 AM ET
Cerenome to Hold CNSide® Business Update Call on September 30, 2026
GlobeNewswire · Sep 25, 2026 7:30 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CNSY's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.